DRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU

Similar documents
By Prof. Khaled El-Rabat

47 Hypertension in Elderly

Antihypertensive Drugs Prescribing Pattern in Patients Attending to Medicine Outpatient Department

Abbreviations Cardiology I

The prevalence of hypertension in a representative

EVALUATION OF BETA BLOCKERS USE AT A TERTIARY CARE HOSPITAL

Long-Term Care Updates

Prescribing Trend of Antihypertensive Drugs in Sri Ganganagar District: A Retrospective Study

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Large therapeutic studies in elderly patients with hypertension

Factors Involved in Poor Control of Risk Factors

STANDARD treatment algorithm mmHg

Volume 2 Number 2 (2011)

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Andhra Pradesh, India Corresponding Author: Dr. S. Parveen *

International Journal of Advancements in Research & Technology, Volume 2, Issue 6, June-2013 ISSN

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

STUDY OF DRUG UITLIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE NEPHROPATHY IN A TERTIARY CARE TEACHING HOSPITAL, BAREILLY, U.P.

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

Antihypertensive drugs: I. Thiazide and other diuretics:

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi

Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines

Should beta blockers remain first-line drugs for hypertension?

Hypertension Pharmacotherapy: A Practical Approach

Metoprolol Succinate SelokenZOC

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 7 January 2009

DRUG UTILIZATION EVALUATION OF ANTI-HYPERTENSIVE AGENTS IN A MEDICAL CARE HOSPITAL

Difficult to Treat Hypertension

Overview of the outcome trials in older patients with isolated systolic hypertension

Disclosures. Hypertension: Nationwide Dilemma. Learning Objectives. What s Currently Recommended? Specific Concerns 3/9/2012

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care

Update in Hypertension

2014 HYPERTENSION GUIDELINES

Treating Hypertension in Individuals with Diabetes

EFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

JMSCR Vol 06 Issue 05 Page May 2018

SINCE ITS INCEPTION IN

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives

Hypertension Update 2009

The problem of uncontrolled hypertension

Managing Hypertension in 2016

Hypertension (JNC-8)

Combining Antihypertensives in People with Diabetes

Diabetes and Hypertension

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

Lowering blood pressure in 2003

Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017

Egyptian Hypertension Guidelines

Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice

Combination Therapy for Hypertension

TRANSPARENCY COMMITTEE OPINION. 21 October 2009

Awareness of and therapy for hypertension in the United States have been increasing in

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 27 May 2009

The underestimated risk of

ANTI- HYPERTENSIVE AGENTS

Hypertension Guidelines: Are We Pressured to Change? Oregon Cardiovascular Symposium Portland, Oregon June 6, Financial Disclosures

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Management of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers. Robert D. Toto, MD

Executive Summary. Different antihypertensive drugs as first line therapy in patients with essential hypertension 1

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Management of Hypertension

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

Chemistry 106: Drugs in Society Lecture 20: How do Drugs Elicit an Effect? Interactions between Drugs and Macromolecular Targets II 5/11/18

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Target Blood Pressure Attainment in Diabetic Hypertensive Patients: Need for more Diuretics? Waleed M. Sweileh, PhD

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

APPENDIX D: PHARMACOTYHERAPY EVIDENCE

The JNC 8 Guidelines: A Clinical Review

Layered Approaches to Studying Drug Responses

Management of High Blood Pressure in Adults

Antihypertensive Trial Design ALLHAT

Cedars Sinai Diabetes. Michael A. Weber

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

Jared Moore, MD, FACP

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?

Phase 3 investigation of aprocitentan for resistant hypertension management. Investor Webcast June 2018

Incidental Findings; Management of patients presenting with high BP. Phil Swales

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Patterns of Anti-hypertensive Therapy in Diabetic Patients with and without Reduced Renal Function

Hypertension Update Clinical Controversies Regarding Age and Race

Guidelines for Integrated Management of. Cardiovascular Diseases and Diabetes. in Clinics and Ri-hospitals

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

Understanding the importance of blood pressure control An overview of new guidelines: How do they impact daily current management?

ADVANCES IN MANAGEMENT OF HYPERTENSION

Clinical Recommendations: Patients with Periodontitis

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Using the New Hypertension Guidelines

DEPARTMENT OF GENERAL MEDICINE WELCOMES

Transcription:

Original Article DRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU V.Gowri 1, K.Punnagai, K.Vijaybabu 3, Dr.Darling Chellathai 4 1 Assistant Professor Department of Pharmacology, SRMC & RI, Porur, Chennai Associate Professor Department of Pharmacology, SRMC & RI, Porur, Chennai 3 Professor, Department of Pharmacology, Annapoorna Medical College, Salem 4 Professor and HOD, Department of Pharmacology, SRMC & RI, Porur, Chennai ABSTRACT Abstract: Drug utilisation study on Antihypertensive datas are useful for implementation of rational use of drugs among population. AIM : The aim of the study is to conduct the prescribing survey of antihypertensives in moderate to severe hypertension and in hypertensive complications by the physicians of a tertiary care hospital. Objectives of the study are to investigate the 1) most commonly used antihypertensive drug groups, ) To determine the preferred drug which suits all age groups and controls symptomatic blood pressure and 3) the antihypertensive drug preferred in diabetes mellitus and hyperlipidemia 4) and to evaluate the regimen commonly followed Result and concultion In this prescription survey, calcium channel blockers were most commonly prescribed drug in monotherapy as well as combination therapy. Beta blockers were most commonly used in patients with hypertension associated cardiovascular disease. Angiotensin converting enzyme inhibitors, angiotensin receptor blockers were most commonly used in concomitant diseases like, diabetes, mellitus and hyperlipidemia INTRODUCTION Drug utilization is defined by the World Health Organization (WHO) as the marketing, distribution, prescription, and use and adverse effects of drugs in society, with special emphasis on the resulting medical, social, and economic consequences. These types of studies are useful for implementation of rational use of drugs among 1 population in both private and public healthcare. Hypertension is a chronic staggering health problem for three reasons as follows: high prevalence, devastating complications, and asymptomatic until late in its course. Randomized clinical trials have demonstrated substantially improved Cardiovascular disease and microvasuclar outcomes with a target diastolic blood pressure, close to or < 80 mmhg41,4. For the prognostically more important systolic blood pressure, a single randomized clinical trial43 and prospective observational data from three other clinical trials44-46 support improved Cardiovascular disease and microvascular outcomes with a target systolic blood pressure <130 mmhg. Based on these data, most international guidelines now recommend a target blood pressure < 130/80 mmhg for people with diabetes35, 47-51. Optimal antihypertensive therapy requires consideration of patient's age, diet, exercise, tobacco use, co morbid conditions, adequate dosing, patient compliance, and optimal blood pressure control. Other issues which deserve scrutiny are accuracy of initial diagnosis, self monitoring of blood pressure and dosage adjustability. According to seventh joint national committee on prevention, detection and treatment of high Blood pressure criterian, addresses current deficiencies as mainly due to underuse, overuse and misuse of antihypertensive medications. But some newer drugs are widely used with little indication, reasons being high cost and massive marketing strategies. This Prescription survey is a part of drug utilization studies to investigate the pattern of antihypertensive drugs or regimen prescribed by the physicians in a tertiary care hospital, Tamilnadu. International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5 103

www.ijbms.com V. Gowri et al; Drug Utilization Patterns of AIM & OBJECTIVES The aim of the study is to conduct the prescribing survey of antihypertensives in moderate to severe hypertension and in hypertensive complications by the physicians of a tertiary care hospital. Objectives of the study are to investigate the 1) most commonly used antihypertensive drug groups, ) To determine the preferred drug which suits all age groups and controls symptomatic blood pressure and 3) the antihypertensive drug preferred in diabetes mellitus and hyperlipidemia 4) and to evaluate the regimen commonly followed for combination therapy. MATERIALS & METHODS This prospective utilization study was done as prescription survey to examine the use of antihypertensive drugs among the inpatients with moderate and high blood pressure. The study protocol was approved by the Institute's human ethical committee. The inclusion criteria includes prescriptions of patients with moderate (systolic BP 160-179 mm Hg, diastolic BP 100-109 mm Hg) and severe hypertension (systolic BP 180 mm Hg and diastolic BP 110mmHg) from 5 to 80 age groups of both sexes, with concomitant medications and comorbid conditions like hyperlipidemia, diabetes mellitus, cardiovascular diseases, neurological disorders and renal diseases. The prescriptions of patients with incomplete treatment, poor patient compliance, mild hypertension, childhood hypertension, and hypertension associated with obstetrics and gynaecology and finally emergency malignant hypertension are excluded. Outpatient prescriptions were also not included in our study of prescription survey. The prescriptions were collected from the inpatients admitted in the wards of medicine, cardiology, neurology, and nephrology wards. The prescriptions were collected during 9 week period of May and June, 006. Total no. 100 prescriptions were collected; patient's name, age, sex, names of the all the drugs prescribed and concomitant diseases like diabetes mellitus and hyperlipidemia, with treatment were recorded using a prescription monitoring proforma. The prescriptions were primarily categorised according to sex, age, Blood pressure (moderate & severe). The sub classifications of prescriptions were also done as follow as: 1) Class of antihypertensive drugs used in the treatment, ) Mode of Therapy of Antihypertensives (monotherapy or combination therapy co administered with other drugs like antidiabetic drugs, lipid lowering drugs, drugs used to treat cardiovascular diseases, drugs used for accompanying neurological disorders and renal diseases), 3) the combination therapy again sub classified into two, three and four drug regimens. These prescriptions under various categories and subcategories were analysed statistically and recorded. The results were shown as percentage. RESULTS A total of 100 prescriptions were collected. Out of 100 patients, 55 patients were male and 45 patients were female. Patients were over the age of 60 years are 4, out of these 4 were men and 18 were women. Minimum age of the hypertensive patient admitted in hospital among both sexes is 40 and maximum age was 76 years. In 100 patients, 84 had moderate hypertension and 16 had severe hypertension (Table 1). In 100 prescriptions, 4 patients received single antihypertensive drugs and 58 received combination therapy. In these total 100 prescriptions, 61 patients received calcium channel blockers, 4 patients received beta adrenergic blockers. Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers were given to 4 and 13 patients respectively. 8 patients were treated with diuretics, 5 patients with alpha blockers and clonidine was given to patients (Table ). In monotherapy category, calcium channel blockers were given to 4 patients and beta blockers were given to 9 patients. Angiotensin converting enzyme inhibitors were given to 8 patients as monotherapy and only one patient was receiving diuretic as 104 International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5

V. Gowri et al; Drug Utilization Patterns of www.ijbms.com monotherapy. Among 58 patients receiving combination therapy, two drug regimens were received by 46 patients. Out of these 46 patients, combination with calcium channel blocker and beta blocker were given to 14 patients (Fig 3). Combination with calcium channel blocker and diuretic were given to 10 patients. 6 patients received Angiotensin converting enzyme inhibitor and diuretic and 5 patients received beta blocker and Angiotensin converting enzyme inhibitor. 1 patient received combination of calcium channel blocker and Angiotensin receptor blocker combination. Three drug combination therapies was given to 8 patients, in those 8 patients beta blocker, Angiotensin receptor blocker and diuretic triple drug therapy were given to 4 patients. patients received calcium channel blocker, beta blocker and alpha blocker combination. Four drug combinations were given to 4 patients. Calcium channel blocker, beta blocker, Angiotensin receptor blocker and diuretic were prescribed in patients. Out of 100 prescriptions, 31 patients were associated with diabetes mellitus and treated. The most commonly used antihypertensive drugs in these patients were Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers. 13 patients were associated with hyperlipidemia and all of them were treated with HMG CoA reductase inhibitors (Table 3). In 61 patients of calcium channel blockers, 40 patients were receiving Amlodipine and 1 patients were receiving Nifedipine (Table 4). Among 4 patients of beta blockers, 3 patients were receiving Atenolol, 6 and 4 patients receiving Metoprolol and Carvedilol (Table 5). In Angiotensin converting enzyme inhibitors, patients were receiving Enalapril and patients were receiving Ramipril (Fig 5). Among diuretics, 18 patients were treated with Furosemide, 9 patients received thiazides and 1 patient received spirinolactone (Fig 6). Losartan was the only drug given in Angiotensin receptor blocker group. International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5 105

www.ijbms.com V. Gowri et al; Drug Utilization Patterns of Anti Hypertensive Drugs either given alone or in Combinations of Prescriptions 1. 3 4 5 6 7 Beta Adrenoceptor Blocking agents Calcium channel blocking agents ACE inhibitors Diuretics Alpha adrenoceptor Blocking agents Angiotensin Receptor Antagonist Clonidine 4 61 4 8 5 13 Number of Prescriptions 100 Male 55 Female 45 Age: of patients over 60 years 4 Male 4 Female 18 Blood Pressure Reading Moderate Hypertension 84 patients (systolic 160-179 mmhg) (diastolic 100 109 mm Hg) Severe Hypertension (systolic > 180 mmhg) 16 patients (diastolic > 110 mmhg) TABLE 1 : DEMOGRAPHIC PROFILE OF THE PATIENTS IN THE PRESCRIPTION SURVEY Table : NUMBER OF PRESCRIPTIONS WITH ANTI-HYPERTENSIVE DRUGS Type of Therapy 1. 3 4 5 6 Monotherapy Combination Therapy Antidiabetic Drugs Lipid Lowering Agents Cardiac Diseases Renal Diseases 4 58 31 13 30 17 7 7 Neurological Disorders TABLE - 3 : PRESCRIBED ANTI HYPERTENSIVE DRUGS WITHCO-ADMINISTRATION OF OTHER DRUGS 106 International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5

V. Gowri et al; Drug Utilization Patterns of www.ijbms.com Monotherapy - 4 out of 100 prescriptions (%) 1. Calcium Channel Blockers (CCB) 4 Beta Blockers 9 3 Angiotensin Converting Enzyme Inhibitors 8 4 Diuretics 1 TABLE - 4 : NO. OF PATIENTS TREATED WITH SINGLE ANTI HYPERTENSIVE DRUG CALCIUM CHANNEL BLOCKERS 61 out of 100 prescriptions (%) 1. Amlodipine 40 Nifedipine 1 TABLE - 5 : NO. OF PATIENTS TREATED WITH CALCIUM CHANNEL BLOCKERS EITHER ALONE OR IN COMBINATIONS Beta Blockers - 4 out of 100 prescriptions (%) 1. Atenolol 3 Metoprolol 6 3 Carvedilol 4 TABLE - 6 : NO. OF PATIENTS TREATED WITH BETA BLOCKERS EITHER ALONE OR IN COMBINATIONS DISCUSSION A prescription survey is considered to be one of the most effective methods to evaluate the prescribing attitude of doctors. It is also important to consider the guidelines of international regulatory associations on the management of hypertension that will improve prescribing practice of the physicians and ultimately, the clinical standards. This practice will eventually, help to promote rational use of drugs. In the present prescription based survey, the prominent findings were, out of 100 prescriptions, elderly males above 60 years were most commonly affected with hypertension. In our survey, combination therapy was most widely prescribed regimen by the physicians. Earlier studies have revealed that an ideal combination must have antihypertensive drugs possessing complementary modes of action that provide a synergistic effect with minimal adverse effects. Most hypertensive diabetic patients with normal renal function require a combination of two to three antihypertensive agents to lower blood pressure to < 130/80 mmhg; patients with concomitant chronic kidney disease may require three or more agents. Combination therapy is required for optimal blood pressure control and prevention of cardiovascular, renal and neurological complications. In this survey, most commonly prescribed monotherapy were calcium channel blockers followed by beta blockers. Very rarely diuretic was used as a monotherapy. In elderly patients, the preferred antihypertensive by the physicians were calcium channel blockers. In two drug combinations, calcium channel blockers with beta blockers were widely prescribed by the physicians, next in line is the combination of calcium channel blockers and diuretics. Less frequently used two drug combination therapy was calcium channel blocker with Angiotensin receptor blocker. In three drug combination therapy, the most common classes of drugs were beta blockers, Angiotensin receptor blockers and diuretics. Less frequent combination is Angiotensin converting enzyme inhibitors, diuretics and beta blockers. The second combination least used is Angiotensin receptor blockers with calcium channel blockers and diuretics.(table 4) In four drug regimen, Calcium channel blockers, beta blockers, Angiotensin receptor blockers, and diuretics were widely used. In individual drug utilization category, Amlodipine was most prescribed calcium channel blocker compared to Nifedipine. Atenolol was most preferred beta blocker followed by Metoprolol and then is Carvedilol. The predominant Angiotensin converting enzyme International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5 107

www.ijbms.com V. Gowri et al; Drug Utilization Patterns of inhibitor used was Enalapril and Ramipril was less frequently used. Among diuretics, Furosemide was popularly prescribed in comparison with thiazide and spirinolactone. In diabetic patients, most widely used drug classes were Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers. In patients with cardiovascular disease, beta blockers were most commonly used. Cardio selective beta blockers were largely used in these patients. Calcium channel blockers were most preferred in elderly patients. All these drugs were well tolerated and patient response was also found to be satisfactory. The major studies have demonstrated decrease in morbidity and mortality in patients treated with either diuretics or ß-blocker Inspite of pharmacotherapy lifestyle modification like exercise, diet, salt restriction, relaxation techniques remains the cornerstone in the management of hypertension All the patients were advised about non pharmacological measures like regular walking, Weight reduction, diet & salt restriction, low carbohydrates, fruits and vegetables consumption. 58% of patients followed life style modification to some extent. 4-14 15. areas of aberrant or sub optimal prescribing for further evaluation. REFERENCES 1. K. Park, Epidemiology of chronic noncommunicable diseases and conditions, hypertension, park's text book of preventive and social medicine, 18th edition, 005; 93-98.. Bodenheimer T. The American health care system: the movement for improved quality in health care. N Engl J. Med 1999, 340: 488-49. 3. Joint National Committee on Prevention, Detection and Treatment of High BP. The sixth report of the Joint National Committee on Prevention, Detection and Treatment of High BP. Arch Intern Med. 1997; 157: 413-446. 4. Jeffrey S. Trilling MD; Jack Froom, MD. The Urgent Need to Improve Hypertension Care. Archives of Family Medicine. 000; 9: 794-801. 5. Smith WM. Treatment of mild hypertension: results of a ten-year intervention trial, Circ Res. 1977; 40 (suppl): 198-105. CONCLUSION In this prescription survey, calcium channel blockers were most commonly prescribed drug in monotherapy as well as combination therapy. Beta blockers were most commonly used in patients with hypertension associated cardiovascular disease. Angiotensin converting enzyme inhibitors, angiotensin receptor blockers were most commonly used in concomitant diseases like, diabetes, mellitus and hyperlipidemia. The most widely prescribed two drug combination therapy was calcium channel blockers and beta blockers. In elderly patients, the preferred antihypertensive by the physicians was calcium channel blockers. Most of the physicians followed the guidelines of international societies but the use of diuretics as a first line therapy both in monotherapy and combination therapy was found to be less. This kind of survey allows the identification of 6. 7. 8. 9. 10. Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial: the Oslo study. Am J Med. 1980; 69 : 75-73. Amery A, Birkenhager W, Brixko P, et al, Mortality and morbidity results from the European Working Party on High BP in the Elderly Trial, Lancet, 1985; 1 : 1349-1354. Stamler J. Risk factor modification trials: implications for the elderly. Eur Heart J. 1988; 9 (Suppl D) : 9-53. Coope J, Warrender TS. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986; 93 : 1145-1151. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P.O. Morbidity and 108 International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5

V. Gowri et al; Drug Utilization Patterns of www.ijbms.com mortality in the Swedish Trial in Old Patients propranolol and placebo in men with mild with Hypertension (STOP-Hypertension). hypertension: a randomized, prospective trial. Lancet. 1991; 338: 181-185. Am Heart J. 199; 13 : 466-474. 11. Staessen JA, Fagard R, Thijs L, et al, 13. Soleimani M, Singh G. Physiologic and Randomised double-blind comparison of molecular aspects of the Na+/H+ exchanges placebo and active treatment for older in health and disease processes. J. Invest Med patients with isolated systolic hypertension. 1995; 43 : 419-30. Lancet. 1997; 350 : 757-764. 14. Siffert WG. Protieins and Hypertension; 1. Kostis JB, Rosen RC, Brondolo E, Taska L, Alternative candidate gene approach, Kidney Smith DE, Wilson AC. Superiority of Int, 1998; 5: 1466-1469. nonpharmacological therapy compared to International Journal of Basic Medical Science - Dec. 014, Vol : 5, Issue : 5 109